[Federal Register Volume 86, Number 208 (Monday, November 1, 2021)]
[Notices]
[Pages 60243-60244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23684]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0118; NIOSH 248-I]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, CDC 
announces the following virtual meeting for the World Trade Center 
Health Program Scientific/Technical Advisory Committee (WTCHP STAC). A 
notice of this WTCHP STAC meeting has also been posted on the committee 
website at: https://www.cdc.gov/wtc/stac_meeting.html.

DATES: The meeting will be held on November 18, 2021, from 11:00 a.m. 
to 4:00 p.m., EST. Comments must be received by November 18, 2021. 
Written public comment received prior to the meeting will be part of 
the official record of the meeting.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0118; NIOSH 248-I by mail. CDC does not accept comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket number CDC-2021-0118; NIOSH 248-I, c/o Sherri 
Diana, NIOSH Docket Office, National Institute for Occupational Safety 
and Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
    Instructions: All submissions received must include the Agency name 
and Docket Number (CDC-2021-0118; NIOSH 248-I). All relevant comments, 
including any personal information provided, will be posted without 
change to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D., 
Designated Federal Officer, World Trade Center Health Program, National 
Institute for Occupational Safety and Health, CDC, 1600 Clifton Road 
NE, MS R-12, Atlanta, GA 30329-4027, Telephone: (513) 841-4515; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The WTCHP STAC was established by Title I of the James 
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347 
(Jan. 2, 2011), as amended by Public Law 114-113 (Dec. 18, 2015) and 
Public Law 116-59 (Sept. 27, 2019), adding Title XXXIII to the Public 
Health Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-61).
    Purpose: The purpose of the WTCHP STAC is to review scientific and 
medical evidence and to make recommendations to the Administrator of 
the World Trade Center (WTC) Health Program regarding additional WTC 
Health Program eligibility criteria, potential additions to the List of 
WTC-Related Health Conditions (List), and research regarding certain 
health conditions related to the September 11, 2001, terrorist attacks.
    Title XXXIII of the PHS Act established the WTC Health Program 
within the Department of Health and Human Services (HHS). The WTC 
Health Program provides medical monitoring and treatment benefits to 
eligible firefighters and related personnel, law enforcement officers, 
and rescue, recovery, and cleanup workers who responded to the 
September 11, 2001, terrorist attacks in New York City, at the 
Pentagon, and in Shanksville, Pennsylvania (responders), and to 
eligible persons who were present in the dust or dust cloud on 
September 11, 2001 or who worked, resided, or attended school, 
childcare, or adult daycare in the New York City disaster area 
(survivors). Certain specific activities of the Administrator of the 
WTC Health Program are reserved to the Secretary, HHS, to delegate at 
his discretion; other duties not explicitly reserved to the Secretary, 
HHS, are assigned to the Director of the National Institute for 
Occupational Safety and Health (NIOSH). The administration of the WTCHP 
STAC is left to the Director of NIOSH in his role as Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the WTCHP STAC. The charter was reissued on May 12, 2021 
and will expire on May 12, 2023.
    Matters To Be Considered: The agenda will include a presentation 
about revisions to the existing Policy and Procedures for Adding Types 
of Cancer to the List of WTC-Related Health Conditions, a report from 
the STAC workgroup regarding adding uterine cancer to the List, 
deliberations by the full committee on the STAC recommendation to the 
Administrator of the WTC Health Program on whether to add uterine 
cancer to the List, and recommendations on peer reviewers to review the 
evaluation of the evidence for adding the health condition to the List. 
The revised draft Policy and Procedures for Adding Types of Cancer to 
the List of WTC-Related Health Conditions is available on the WTC 
Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. An 
agenda is also posted on the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. Agenda items are subject to change 
as priorities dictate.
    Meeting Information: This is a virtual meeting conducted via Zoom. 
The public is welcome to follow the proceedings via live webcast. No 
registration is required. The webcast link for November 18, 2021 is 
https://www.ustream.tv/channel/QyXBRzYjVCS. For additional information 
please visit the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.

Public Participation

    Interested parties may participate in this activity by submitting 
written views, opinions, recommendations, and data. You may submit 
comments on any topic related to this activity. Comments received, 
including attachments and other supporting materials, are part of the 
public record and subject to public disclosure. Do not include any 
information in your comment or supporting materials that you consider 
confidential or inappropriate for public disclosure. If you include 
your name, contact information, or other information that identifies 
you in the body of your comments, that information will be on public 
display. CDC will review all submissions and may choose to redact, or 
withhold, submissions containing private or proprietary information 
such as Social Security numbers, medical information, inappropriate 
language, or duplicate/near duplicate examples of a mass-mail campaign. 
CDC will carefully consider all comments submitted into the docket. CDC 
does not accept comment by email.
    Oral Public Comment: The public is welcome to participate, via 
Zoom, during the public comment period on November 18, 2021, from 1:00 
p.m. to 1:30 p.m., EST. Please note that the public comment period ends 
at the time indicated above. Each commenter will be provided up to five 
minutes for comment. A limited number of time slots are available and 
will be assigned on a first come-first served basis.

[[Page 60244]]

Members of the public who wish to address the WTCHP STAC during the 
oral public comment sessions must sign up by providing their name to 
Mia Wallace, Committee Management Specialist, via email: 
[email protected], or the addresses section provided in this notice by 
November 12, 2021.
    Written Public Comment: Written comments will also be accepted per 
the instructions provided in the addresses section above. Written 
public comment received prior to the meeting will be part of the 
official record of the meeting. The docket will close on November 18, 
2021.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives their name, no attempt will be made to redact 
that name. NIOSH will take reasonable steps to ensure that individuals 
making public comments are aware that their comments (including their 
name, if provided) will appear in a transcript of the meeting posted on 
a public website. Such reasonable steps include a statement read at the 
start of the meeting stating that transcripts will be posted, and names 
of speakers will not be redacted. If individuals in making a statement 
reveal personal information (e.g., medical information) about 
themselves, that information will not usually be redacted. The CDC 
Freedom of Information Act coordinator will, however, review such 
revelations in accordance with the Freedom of Information Act and, if 
deemed appropriate, will redact such information. Disclosures of 
information concerning third party medical information will be 
redacted.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-23684 Filed 10-29-21; 8:45 am]
BILLING CODE 4163-18-P